Shannon K. McWeeney

18.1k total citations · 2 hit papers
202 papers, 7.2k citations indexed

About

Shannon K. McWeeney is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Shannon K. McWeeney has authored 202 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 50 papers in Hematology and 39 papers in Genetics. Recurrent topics in Shannon K. McWeeney's work include Acute Myeloid Leukemia Research (33 papers), Bioinformatics and Genomic Networks (25 papers) and Chronic Myeloid Leukemia Treatments (25 papers). Shannon K. McWeeney is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Bioinformatics and Genomic Networks (25 papers) and Chronic Myeloid Leukemia Treatments (25 papers). Shannon K. McWeeney collaborates with scholars based in United States, India and Switzerland. Shannon K. McWeeney's co-authors include Daniel Bottomly, Gregory S. Yochum, Beth Wilmot, Jeffrey Tyner, Richard H. Goodman, Robert Hitzemann, Brian Druker, Sophia Jeng, Gail Mandel and Robert P. Searles and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Shannon K. McWeeney

196 papers receiving 7.2k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining the CREB Regulon

2004 595 citations Shannon K. McWeeney, Gail Mandel et al. profile →
OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML

2013 356 citations Julia E. Maxson, Christopher A. Eide et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shannon K. McWeeney United States	46	3.8k	1.2k	1.0k	906	864	202	7.2k
Peter J. van der Spek Netherlands	55	7.0k 1.9×	1.4k 1.1×	1.4k 1.3×	1.0k 1.1×	713 0.8×	252	12.6k
Nathan Salomonis United States	43	4.4k 1.2×	781 0.6×	496 0.5×	1.4k 1.6×	462 0.5×	129	7.1k
Melanie Bahlo Australia	47	3.3k 0.9×	639 0.5×	2.1k 2.1×	1.5k 1.7×	1.4k 1.6×	203	9.3k
Sung Sup Park South Korea	45	2.7k 0.7×	618 0.5×	1.7k 1.7×	450 0.5×	796 0.9×	348	7.4k
John R. Walker United States	52	6.9k 1.8×	594 0.5×	1.3k 1.3×	1.2k 1.3×	1.0k 1.2×	121	11.9k
Dennis Huszar United States	42	3.1k 0.8×	398 0.3×	1.1k 1.1×	1.7k 1.9×	985 1.1×	86	8.7k
Lihua Julie Zhu United States	54	6.8k 1.8×	383 0.3×	1.2k 1.2×	656 0.7×	734 0.8×	165	9.3k
Esteban Ballestar Spain	55	9.1k 2.4×	609 0.5×	1.6k 1.6×	1.9k 2.1×	966 1.1×	147	12.6k
Richard A. Spritz United States	63	5.5k 1.5×	708 0.6×	1.8k 1.8×	3.0k 3.3×	504 0.6×	210	12.5k
Iain D. C. Fraser United States	43	4.2k 1.1×	588 0.5×	495 0.5×	1.6k 1.8×	521 0.6×	149	7.5k

Countries citing papers authored by Shannon K. McWeeney

Since Specialization

Citations

This map shows the geographic impact of Shannon K. McWeeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon K. McWeeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon K. McWeeney more than expected).

Fields of papers citing papers by Shannon K. McWeeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon K. McWeeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon K. McWeeney. The network helps show where Shannon K. McWeeney may publish in the future.

Co-authorship network of co-authors of Shannon K. McWeeney

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon K. McWeeney. A scholar is included among the top collaborators of Shannon K. McWeeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon K. McWeeney. Shannon K. McWeeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coleman, Daniel J., Joseph Estabrook, Emek Demir, et al.. (2023). Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia. Molecular Cancer Research. 21(7). 631–647. 5 indexed citations

Nazha, Aziz, et al.. (2023). How I read an article that uses machine learning methods. Blood Advances. 7(16). 4550–4554. 3 indexed citations

Romine, Kyle A., et al.. (2023). Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia. Frontiers in Oncology. 13. 1192829–1192829. 1 indexed citations

Iizuka, Shinji, Manuela Quintavalle, Robert Ardecky, et al.. (2021). Serine-Threonine Kinase TAO3-Mediated Trafficking of Endosomes Containing the Invadopodia Scaffold TKS5α Promotes Cancer Invasion and Tumor Growth. Cancer Research. 81(6). 1472–1485. 13 indexed citations

Yenerall, Paul, Rahul K. Kollipara, Michael Peyton, et al.. (2021). Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations. Cancer Research. 81(18). 4685–4695. 6 indexed citations

Romine, Kyle A., Tamilla Nechiporuk, Daniel Bottomly, et al.. (2021). Monocytic Differentiation and AHR Signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia. Blood Cancer Discovery. 2(5). 518–531. 22 indexed citations

Graham, Jessica B., Sarah R. Leist, Alexandra Schäfer, et al.. (2021). Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice. PLoS Pathogens. 17(1). e1009287–e1009287. 18 indexed citations

Zhang, Haijiao, Yusuke Nakauchi, Thomas Köhnke, et al.. (2020). Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia. Nature Cancer. 1(8). 826–839. 121 indexed citations

Nechiporuk, Tamilla, Stephen E. Kurtz, Olga Nikolova, et al.. (2019). The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells. Cancer Discovery. 9(7). 910–925. 222 indexed citations

10.

Swanson, Elizabeth A., Jonathan W. Nelson, Sophia Jeng, et al.. (2019). Salt-sensitive transcriptome of isolated kidney distal tubule cells. Physiological Genomics. 51(4). 125–135. 9 indexed citations

11.

Wu, Guanming, et al.. (2019). Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway. Blood Advances. 3(20). 3038–3051. 14 indexed citations

12.

Zhang, Haijiao, Anna Reister Schultz, Kevin Watanabe‐Smith, et al.. (2017). Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function. Cancer Research. 77(16). 4258–4267. 10 indexed citations

13.

Nechiporuk, Tamilla, Sophia Jeng, Shannon K. McWeeney, et al.. (2017). REST corepressors RCOR1 and RCOR2 and the repressor INSM1 regulate the proliferation–differentiation balance in the developing brain. Proceedings of the National Academy of Sciences. 114(3). E406–E415. 52 indexed citations

14.

Smith, Jessica L., Sophia Jeng, Shannon K. McWeeney, & Alec J. Hirsch. (2017). A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection. Journal of Virology. 91(8). 103 indexed citations

15.

Mooney, Michael A., Shannon K. McWeeney, Stephen V. Faraone, et al.. (2016). Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 171(6). 815–826. 34 indexed citations

16.

Maxson, Julia E., Melissa L. Abel, Jinhua Wang, et al.. (2016). Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis. Cancer Research. 76(1). 127–138. 26 indexed citations

17.

Maxson, Julia E., Monika A. Davare, Samuel B. Luty, et al.. (2015). Therapeutically Targetable ALK Mutations in Leukemia. Cancer Research. 75(11). 2146–2150. 17 indexed citations

18.

Swarbrick, Gwendolyn, Meghan Cansler, Megan Null, et al.. (2013). Human Mycobacterium tuberculosis CD8 T Cell Antigens/Epitopes Identified by a Proteomic Peptide Library. PLoS ONE. 8(6). e67016–e67016. 41 indexed citations

19.

Sottoriva, Andrea, Joost J.C. Verhoeff, Tijana Borovski, et al.. (2010). Cancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity. Cancer Research. 70(1). 46–56. 151 indexed citations

20.

Tian, Wei, Yi Fu, Anna García-Elías, et al.. (2009). A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proceedings of the National Academy of Sciences. 106(33). 14034–14039. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact